Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-01-19-Speech-4-298-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120119.24.4-298-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"A Commission report on the implementation of this directive identified certain weaknesses and areas where updates and improvement are needed. Here are the key elements of the agreement: approved active substances will be included in a Union list; derogation from mutual recognition of national authorisations – under certain conditions, Member States have the possibility to refuse to grant an authorisation or to adjust the terms and conditions of an authorisation for a biocidal product if there are specific concerns; inclusion of a new article on measures to achieve the objective of sustainable use of biocidal products; labelling requirements. I voted in favour."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples